This inventor holds 1 USPTO granted patent. Top assignee: Ivax Pharmaceuticals S.r.o.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Roman Sobotik: Innovator in Pharmaceutical Crystallization
Introduction
Roman Sobotik is a notable inventor based in Opava, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new crystalline forms of cabergoline. His work has implications for the effectiveness and stability of this important medication.
Latest Patents
Roman Sobotik holds 1 patent related to his research. His patent, titled "Polymorphs of cabergoline," introduces new crystalline forms VIII, IX, XI, XII, XIV, XV, XVI, XVII, and XVIII of cabergoline. Additionally, he has provided novel processes for the preparation of cabergoline Form I, Form II, Form VII, and amorphous cabergoline. This innovation enhances the pharmaceutical applications of cabergoline, offering new avenues for its use.
Career Highlights
Sobotik is associated with Ivax Pharmaceuticals S.r.o., where he has been instrumental in advancing research and development in pharmaceutical formulations. His expertise in crystallization processes has positioned him as a key player in the industry.
Collaborations
Roman Sobotik has collaborated with notable colleagues, including Roman Bednár and Ladislav Cvak. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Roman Sobotik's contributions to the field of pharmaceuticals through his patent on cabergoline polymorphs exemplify the importance of innovation in drug development. His work continues to influence the pharmaceutical industry positively.